Addictions, Drug & Alcohol Institute
Addictions, Drug & Alcohol Institute > ADAI Publications

ADAI Publications

1331 publications found

  1. Fairlie AM, Jaffee AE, Davis KC, Litt DM, Kaysen D, Norris J, Lewis MA. Establishing a new measure of alcohol-related sexual consequences and examining its association to alcohol consequences among at-risk young adults. Journal of Studies on Alcohol and Drugs 2021;82(4):593-502. [doi: 10.15288/jsad.2021.82.493] PMID: 34343081 PMCID: PMC8356789
  2. Peavy KM, Banta-Green C, Owens M. Opioids and Stimulants: What Are They and How Are People Using Them? Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, April 2021
  3. Kingston S. WA State Project to Prevent Prescription Drug/Opioid Overdose: Final Report on Naloxone Distribution, September 1, 2016 – August 31, 2021. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, November 2021
  4. Peavy KM, Banta-Green C, Owens M. Helping People Who Use Opioids and Stimulants. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, April 2021
  5. Parker M, Duran B, Rhew I, Magarati M, Egashira L, Larimer M, Donovan DM. Prevalence of moderate and acute suicidal ideation among a national sample of tribal college and university students 2014–2015. Archives of Suicide Research 2021;25(3):406-423. [doi: 10.1080/13811118.2019.1691691] PMID: 31769351 PMCID: PMC7739486
  6. Banta-Green CJ, Williams J. Dramatic Increases in Opioid Overdose Deaths Due to Fentanyl Among Young People in Washington State. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, December 2021
  7. Rosa C, Marsch LA, Winstanley EL, Brunner M, Campbell ANC. Using digital technologies in clinical trials: Current and future applications. Contemporary Clinical Trials 2021;100:106219. [doi: 10.1016/j.cct.2020.106219] PMID: 33212293 PMCID: PMC8734581
  8. Shih RA, Tucker JS, Pedersen ER, Seelam R, Dunbar MS, Kofner A, Firth C, D'Amico EJ. Density of medical and recreational cannabis outlets: racial/ethnic differences in the associations with young adult intentions to use cannabis, e-cigarettes, and cannabis mixed with tobacco/nicotine. Journal of Cannabis Research 2021;3(1):28. [doi: 10.1186/s42238-021-00084-y] PMID: 34243820 PMCID: PMC8272320
  9. Hatch-Maillette MA, Peavy KM, Tsui JI, Banta-Green CJ, Woolworth S, Grekin P. Re-thinking patient stability for methadone in opioid treatment programs during a global pandemic: Provider perspectives. Journal of Substance Abuse Treatment 2021;124:108223. [doi: 10.1016/j.jsat.2020.108223] PMID: 33342667 PMCID: PMC8005420
  10. Firth CL, Baquero B, Berney R, Hoerster KD, Mooney SJ, Winters W. Not quite a block party: COVID-19 street reallocation programs in Seattle WA and Vancouver, BC. SSM - Population Health 2021;14:100769. [doi: 10.1016/j.ssmph.2021.100769] PMID: 33748391 PMCID: PMC7966863
  11. Newman A, Kingston S. Housing Program Staff Want More Training to Address Substance Use Among Residents. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, December 2021
  12. McDonell MG, Hirchak KA, Herron J, Lyons AJ, Alcover KC, Shaw J, Kordas G, Dirks LG, Jansen K, Avey J, Lillie K, Donovan D, McPherson SM, Dillard D, Ries R, Roll J, Buchwald D, HONOR Study Team. Effect of incentives on alcohol abstinence with three American Indian and Alaska Native communities: A multi-site randomized controlled trial. JAMA Psychiatry 2021;78(6):599-606. [doi: 10.1001/jamapsychiatry.2020.4768] PMID: 33656561 PMCID: PMC7931140
  13. Pedersen ER, Firth C, Rodriguez A, Shih RA, Seelam R, Kraus L, Dunbar MS, Tucker JS, Kilmer B, D'Amico EJ. Examining associations between licensed and unlicensed outlet density and cannabis outcomes from preopening to postopening of recreational cannabis outlets. American Journal on Addictions 2021;30(2):122-130. [doi: 10.1111/ajad.13132] PMID: 33378105 PMCID: PMC8157480
  14. Banta-Green CJ, Hansen RN, Ossiander EM, Wasserman CR, Merrill JO. Buprenorphine utilization among all Washington State residents’ based upon prescription monitoring program data – Characteristics associated with two measures of retention and patterns of care over time. Journal of Substance Abuse Treatment 2021;127:108446. [doi: 10.1016/j.jsat.2021.108446] PMID: 34049724
  15. Lyons VH, Floyd AS, Griffin E, Wang J, Hajat A, Carone M, Benkeser D, Whiteside LK, Haggerty KP, Rivara FP, Rowhani-Rahbar A. Helping individuals with firearm injuries: A cluster randomized trial. Journal of Trauma and Acute Care Surgery 2021;90(4):722-730. [doi: 10.1097/TA.0000000000003056] PMID: 33405475 PMCID: PMC7979484
  16. Becker SJ, Murphy CM, Hartzler B, Rash CJ, Janssen T, Roosa M, Madden L, Garner BR. Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics): A Cluster-randomized type 3 hybrid effectiveness-implementation trial. Addiction Science & Clinical Practice 2021;16:61. [doi: 10.1186/s13722-021-00268-0] PMID: 34635178 PMCID: PMC8505014
  17. Peavy KM, Banta-Green C. Group Counseling for People in Medication Treatment for Opioid Use Disorder. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, June 2021
  18. Fiala S, Dilley J, Everson E, Firth C, Maher J. Youth exposure to marijuana advertising in Oregon’s legal retail marijuana market. Preventing Chronic Disease 2020;17:E110. [doi: 10.5888/pcd17.190206] PMID: 32975510 PMCID: PMC7553221
  19. Hirchak K, Jansen K, Lyons AJ, Herron J, Bergerson D, Shaw J, Dirks LG, Avey J, Calhoun D, Jackson C, Lauch L, Donovan DM, McPherson SM, Echo-Hawk A, Dillard D, Lillie K, Roll J, Buchwald D, McDonell MG, HONOR Study Team. Lessons shared: Implementation of a randomized clinical trial for alcohol use disorders with five American Indian and Alaska Native communities. Collaborations 2021;4(1):5 [doi: 10.33596/coll.76]
  20. Jacka B, Janssen T, Garner BR, Yermash J, Yap K, Murphy CM, Hartzler B, Becker SJ. Impacts of the COVID-19 pandemic on healthcare access among patients receiving medication for opioid use disorder. Drug and Alcohol Dependence 2021;221:108617. [doi: 10.1016/j.drugalcdep.2021.108617] PMID: 33647590 PMCID: PMC7883735
  21. Peavy KM, Banta-Green C. Understanding and Supporting Adolescents with an Opioid Use Disorder. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, June 2021
  22. Whiteside LK, Huynh L, Morse S, Hall J, Meurer W, Banta-Green CJ, Scheuer H, Cunningham R, McGovern M, Zatzick DF. The Emergency Department Longitudinal Integrated Care (ED-LINC) intervention targeting opioid use disorder: A pilot randomized clinical trial. Journal of Substance Abuse Treatment 2021:108666. [doi: 10.1016/j.jsat.2021.108666] PMID: 34952745 PMCID: PMC9056018
  23. Parker M, Duran B, Rhew I, Margarati M, Larimer M, Donovan DM. Risk and protective factors associated with moderate and acute suicidal ideation among a national sample of Tribal College and University students, 2015-2016. Journal of Rural Health 2021;37(3):545-553. [doi: 10.1111/jrh.12510] PMID: 32894614
  24. Banta-Green C, Kingston S, Newman A. Acute Consequences of Methamphetamine Use Among Participants of Syringe Exchange Programs. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, February 2021
  25. Becker SJ, Garner BR, Hartzler BJ. Is necessity also the mother of implementation? COVID-19 and the implementation of evidence-based treatments for opioid use disorders. Journal of Substance Abuse Treatment 2021;122:108210. [doi: 10.1016/j.jsat.2020.108210] PMID: 33509413 PMCID: PMC7834027
  26. Floyd AS, Lyons VH, Whiteside LK, Haggerty KP, Rivara FP, Rowhani-Rahbar A. Barriers to recruitment, retention and intervention delivery in a randomized trial among patients with firearm injuries. Injury Epidemiology 2021;8:37. [doi: 10.1186/s40621-021-00331-z] PMID: 34304738 PMCID: PMC8311948
  27. Teadt S, Newman A. “Your ‘give a damn’ just really stops giving a damn”: Perspectives of people who use methamphetamine on reducing or stopping their use. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, October 2021
  28. Musyoka C, Mbwayo A, Donovan DM, Mathai M. mHealth-based peer mentoring for prevention of alcohol and substance abuse among first year university students: Protocol for quasi-experimental intervention. Journal of Substance Use 2021;26(1):53-59. [doi: 10.1080/14659891.2020.1766131]
  29. Dalve K, Gause E, Mills B, Floyd AS, Rivara FP, Rowhani-Rahbar A. Neighborhood disadvantage and firearm injury: does shooting location matter? Injury Epidemiology 2021;8,10. [doi: 10.1186/s40621-021-00304-2] PMID: 33678193 PMCID: PMC7938602
  30. Molfenter T, Roget N, Chaple M, Behlman S, Cody O, Hartzler B, Johnson E, Nichols M, Stilen P, Becker SJ. Use of telehealth in substance use disorder services during and after COVID-19: Online survey study. JMIR Ment Health 2021;8(2):e25835. [doi: 10.2196/25835] PMID: 33481760 PMCID: PMC7895293
  31. Schauer GL, Dilley JA, Roehler DR, Sheehy TJ, Dilley JR, Broschart SC, Holland KM, Baldwin GT, Holmes-Chavez AK, Hoots BE. Cannabis sales increases during COVID-19: Findings from Alaska, Colorado, Oregon, and Washington. International Journal of Drug Policy 2021;98:103384. [doi: 10.1016/j.drugpo.2021.103384] PMID: 34364201 PMCID: PMC9759692
  32. Roache JD, Pavlicova M, Campbell ANC, Choo T, Peavy M, Kermack AS, Nunes EV, Rotrosen J. Is extended release naltrexone superior to buprenorphine-naloxone to reduce drinking among outpatients receiving treatment for opioid use disorder? A secondary analysis of the CTN X:BOT trial. Alcohol: Clinical & Experimental Research 2021;45(12):2569-2578. [doi: 10.1111/acer.14729] PMID: 34698397 PMCID: PMC8722377
  33. van Tilburg MAL, Levy RL, Stoner S, Romano JM, Murphy TB, Abdullah B, Manci L, Feld AD. Mediation of outcomes for cognitive behavioral therapy targeted to parents of children with functional abdominal pain disorders. Journal of Psychosomatic Research 2021;150:110618. [doi: 10.1016/j.jpsychores.2021.110618] PMID: 34598050 PMCID: PMC8526395
  34. Haggerty KP, Carlini BH. Commentary: Understanding the intergenerational transmission of substance use and problem behavior: Implications for future research and preventive interventions. Psychology of Addictive Behaviors 2020;34(8):894-897. [doi: 10.1037/adb0000624]
  35. Hartzler B, Vandersloot D. The role of an intermediary purveyor organization in identifying and responding to workforce priorities to combat the opioid epidemic [conference abstract]. Addiction Science & Clinical Practice 2020;15(suppl2):A65. [doi: 10.1186/s13722-020-00208-4]
  36. Larimer ME, Parker M, Lostutter T, Rhew I, Eakins D, Lynch A, Walter T, Egashira L, Kipp BJ, Duran B. Perceived descriptive norms for alcohol use among tribal college students: Relation to self-reported alcohol use, consequences, and risk for alcohol use disorder. Addictive Behaviors 2020;102:106158. [doi: 10.1016/j.addbeh.2019.106158] PMID: 31830672
  37. Hildebrandt UC, Graham JC, Grant TM. Predictors and moderators of improved social-emotional functioning in mothers with substance use disorders and their young children enrolled in a relationship-based case management program. Infant Mental Health Journal 2020;41(5):677-696. [doi: 10.1002/imhj.21872] PMID: 32578238
  38. Firth CL, Hajat A, Dilley J, Braun M, Maher JE. Implications of cannabis legalization on juvenile justice outcomes and racial disparities. American Journal of Preventive Medicine 2020;58(4):562-569. [doi: 10.1016/j.amepre.2019.11.019] PMID: 32033855 PMCID: PMC7266456
  39. Hendershot CS, Dermody SS, Wardell JD, Zaso MJ, Kennedy JL, Stoner SA. OPRM1 moderates daily associations of naltrexone adherence with alcohol consumption: preliminary evidence from a mobile health trial. Alcohol: Clinical & Experimental Research 2020;44(4):983-991. [doi: 10.1111/acer.14300] PMID: 32020635 PMCID: PMC8758337
  40. Harwick R, Carlini BH, Garrett SB. A taxonomy of consumers’ perspectives on the function of cannabis in their lives: A qualitative study in WA State, USA. Journal of Psychoactive Drugs 2020;52(5):393-400. [doi: 10.1080/02791072.2020.1763522] PMID: 32501752
  41. Becker SJ, Garner B, Hartzler B, Rash C, Murphy C, Moul S, Yap K, Yermash J, Ball E, Roosa M, Madden L. Maximizing implementation of contingency management in opioid treatment programs: Process data from the first cohort of a type 3 hybrid trial. [conference abstract]. Addiction Science & Clinical Practice 2020;15(suppl2):A60. [doi: 10.1186/s13722-020-00208-4]
  42. Hallgren K, Witwer E, West I, Baldwin LM, Donovan DM, Stuvek BK, Keppel G, Mollis B, Stephens K. Prevalence of documented alcohol and opioid use disorder diagnoses and treatments in a regional primary care practice-based research network. Journal of Substance Abuse Treatment 2020;110:18-27. [doi: 10.1016/j.jsat.2019.11.008] PMID: 31952624 PMCID: PMC7255441
  43. Haggerty KP, Carlini BH. Understanding the intergenerational transmission of substance use and problem behavior: Implications for future research and preventive interventions. Psychology of Addictive Behaviors 2020;34(8):894-897 [doi: 10.1037/adb0000624] PMID: 33271036
  44. Lyons VH, Benson LR, Griffin E, Floyd AS, Kiche SW, Haggerty KP, Whiteside L, Conover S, Herman DB, Rivara FP, Rowhani-Rahbar A. Fidelity assessment of a social work-led intervention among patients with firearm injuries. Research on Social Work Practice 2020;30(6):378-687. [doi: 10.1177/1049731520912002] PMID: 32973371 PMCID: PMC7508463
  45. Banta-Green CJ, Tinsley J, Hood J, Glick S, Finegood B, Williams J, Smith R. National Drug Early Warning System (NDEWS) Seattle Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2020. College Park, MD: Center for Substance Abuse Research, National Institute on Drug Abuse, August 2020, 18p.
  46. Firth CL, Davenport S, Smart R, Dilley J. How high: Differences in the developments of cannabis markets in two legalized states. International Journal of Drug Policy 2020;75:102611. [doi: 10.1016/j.drugpo.2019.102611] PMID: 31786435 PMCID: PMC7041961
  47. Firth C, Carlini BH, Dilley J, Wakefield J, Hajat A. Moving towards equity: Neighborhood deprivation and cannabis retailers across Portland, Oregon. Cannabis 2020;3(2):157-172
  48. Yap K, Fuentes D, Moul S, Murphy C, Hartzler B, Garner B, Becker SJ. Influence of opioid treatment provider attitudes on skill and knowledge after contingency management training. [conference abstract]. Addiction Science and Clinical Practice 2020;15(suppl2):A57. [doi: 10.1186/s13722-020-00208-4]
  49. Crummy EA, Donckels EA, Baskin BM, Bentzley BS, Ferguson SM. The impact of cocaine and heroin drug history on motivation and cue sensitivity in a rat model of polydrug abuse. Psychopharmacology 2020;237(1):55-68. [doi: 10.1007/s00213-019-05349-2] PMID: 31463541 PMCID: PMC7458349
  50. Banta-Green CJ, Newman A, Kingston S, Glick S, Tinsley J. Washington State Syringe Exchange Health Survey, 2019 Results. Seattle, WA: Alcohol & Drug Abuse Institute, University of Washington, 2020